May 14, 2026
In Part 2, Pranav Garimella discusses major advances in diabetic kidney disease management. Learn how sodium-glucose cotransporter 2 (SGLT2) inhibitors and novel therapies are reshaping disease progression, and why early intervention is critical to improving long-term outcomes.
Timestamps:
01:07 – Practice-changing developments
05:10 – GLP-1 agonists
07:00 – Early intervention
08:43 – Unmet needs